PTGS2 and esophageal squamous cell carcinoma: It shows that miR-101 is down-regulated in ESCC tumor tissues and cell lines, and that it is able to inhibit cell proliferation, migration and invasion of ESCC cells in vitro as well as reduce xenograft tumor growth and the number of metastatic nodules on the surface of the liver in vivo by targeting COX-2.